- Home
- BNTC vs NATH Comparison
BNTC vs NATH Comparison
Compare BNTC & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTC | NATH |
|---|---|---|
| Founded | 1995 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.0M | 411.8M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BNTC | NATH |
|---|---|---|
| Price | $11.38 | $100.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | ★ 167.2K | 41.9K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | ★ 80.94 | 22.29 |
| EPS | N/A | ★ 4.17 |
| Revenue | N/A | ★ $104,201,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.06 |
| Revenue Growth | N/A | ★ 7.81 |
| 52 Week Low | $9.85 | $88.00 |
| 52 Week High | $17.15 | $118.32 |
Technical Indicators
Market Signals| Indicator | BNTC | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 51.96 | 52.83 |
| Support Level | $11.30 | $100.25 |
| Resistance Level | $12.75 | $101.86 |
| Average True Range (ATR) | 0.73 | 0.49 |
| MACD | 0.07 | -0.25 |
| Stochastic Oscillator | 90.34 | 8.06 |
Price Performance
Historical ComparisonAbout BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.